October 2008 Volume 15 Number 10, pp 625 - 692
---------------------------------------------------------------------
This alert is sponsored by Agilent Technologies
Stock up on Agilent CGH microarrays
See the genome with unparalleled clarity using the industry standard
in CGH microarrays - from Agilent. For a limited time, take advantage
of 25% off of any CGH microarrays (catalog kits, custom, or
unrestricted).
Purchase up to a maximum quantity of 5 kits or 25 individual slides.
http://ealerts.nature.com/cgi-bin24/DM/y/enTh0Xztnp0Hhs0B5Jo0EW
---------------------------------------------------------------------
Announcing the NEW British Journal of Cancer website with enhanced
functionality
Visit http://ealerts.nature.com/cgi-bin24/DM/y/enTh0Xztnp0Hhs0f8c0Ej and benefit from new features,
including RSS Web Feeds, Article Links and Top Ten downloaded
articles.
---------------------------------------------------------------------
Advance Online Publication
http://ealerts.nature.com/cgi-bin24/DM/y/enTh0Xztnp0Hhs0BU8t0Ep
Articles for this journal are published online ahead of print
through Advance Online Publication (AOP), meaning that the latest
research reaches you in the timeliest way possible. Check the AOP
webpage each week to make sure that you are not left behind:
http://ealerts.nature.com/cgi-bin24/DM/y/enTh0Xztnp0Hhs0BU8t0Ep
----------------------
ORIGINAL ARTICLES
----------------------
Chimeric adenoviral vector Ad5/F35-mediated APE1 siRNA enhances
sensitivity of human colorectal cancer cells to radiotherapy in vitro
and in vivo
D-B Xiang, Z-T Chen, D Wang, M-X Li, J-Y Xie, Y-S Zhang, Y Qing, Z-P
Li and J Xie
Abstract:
http://ealerts.nature.com/cgi-bin24/DM/y/enTh0Xztnp0Hhs0B5Jp0EX
Article:
http://ealerts.nature.com/cgi-bin24/DM/y/enTh0Xztnp0Hhs0B5Jq0EY
Dual induction of PKR with E2F-1 and IFN-[alpha] to enhance gene
therapy against hepatocellular carcinoma
V Roh, A Laemmle, U Von Holzen, D Stroka, J-F Dufour, K K Hunt, D
Candinas and S A Vorburger
Abstract:
http://ealerts.nature.com/cgi-bin24/DM/y/enTh0Xztnp0Hhs0B5Jr0EZ
Article:
http://ealerts.nature.com/cgi-bin24/DM/y/enTh0Xztnp0Hhs0B5Js0Ea
Hypoxia-induced human endonuclease G expression suppresses tumor
growth in a xenograft model
P T Winnard, M Botlagunta, J B Kluth, S Mukadam, B Krishnamachary, F
Vesuna and V Raman
Abstract:
http://ealerts.nature.com/cgi-bin24/DM/y/enTh0Xztnp0Hhs0B5Jt0Eb
Article:
http://ealerts.nature.com/cgi-bin24/DM/y/enTh0Xztnp0Hhs0B5Ju0Ec
Vaccination of fiber-modified adenovirus-transfected dendritic cells
to express HER-2/neu stimulates efficient HER-2/neu-specific humoral
and CTL responses and reduces breast carcinogenesis in transgenic mice
S Sas, T Chan, A Sami, A El-Gayed and J Xiang
Abstract:
http://ealerts.nature.com/cgi-bin24/DM/y/enTh0Xztnp0Hhs0B5Jv0Ed
Article:
http://ealerts.nature.com/cgi-bin24/DM/y/enTh0Xztnp0Hhs0B5Jw0Ee
Cancer gene therapy with iCaspase-9 transcriptionally targeted to
tumor endothelial cells
W Song, Z Dong, T Jin, M G Mantellini, G Nunez and J E Nor
Abstract:
http://ealerts.nature.com/cgi-bin24/DM/y/enTh0Xztnp0Hhs0B5Jx0Ef
Article:
http://ealerts.nature.com/cgi-bin24/DM/y/enTh0Xztnp0Hhs0B5Jy0Eg
Phase I trial of DNA-hsp65 immunotherapy for advanced squamous cell
carcinoma of the head and neck
P Michaluart, K A Abdallah, F D Lima, R Smith, R A Moyses, V Coelho, G
D Victora, A Socorro-Silva, E C Volsi, C R Zarate-Blades, A R Ferraz,
A K Barreto, M C Chammas, R Gomes, E Gebrim, L Arakawa-Sugueno, K P
Fernandes, P A Lotufo, M R Cardoso, J Kalil and C L Silva
Abstract:
http://ealerts.nature.com/cgi-bin24/DM/y/enTh0Xztnp0Hhs0B5Jz0Eh
Article:
http://ealerts.nature.com/cgi-bin24/DM/y/enTh0Xztnp0Hhs0B5J10EU
Tissue-type plasminogen activator has antiangiogenic properties
without effect on tumor growth in a rat C6 glioma model
F Solly, R Fish, B Simard, N Bolle, E Kruithof, B Polack and G Pernod
Abstract:
http://ealerts.nature.com/cgi-bin24/DM/y/enTh0Xztnp0Hhs0B5J20EV
Article:
http://ealerts.nature.com/cgi-bin24/DM/y/enTh0Xztnp0Hhs0B5J30EW
---------------------------------------------------------------------
Leukemia - Celebrating 20 years of distinguished research
Leukemia covers all aspects of research and treatment of leukemia and
allied diseases. It brings the science community the latest advances
in Oncogenes, Growth factors, Stem cells, Leukemia genomics, Cell
cycle,
Signal transduction, Molecular targets for therapy.
Visit http://ealerts.nature.com/cgi-bin24/DM/y/enTh0Xztnp0Hhs0U6k0EY for a variety of free
featured articles and special promotions throughout the year.
======================================================================
You have been sent this Table of Contents Alert because you have opted in to receive it.
You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at:
http://www.nature.com/myaccount
(You will need to log in to be recognised as a nature.com registrant).
For further technical assistance, please contact our registration department:
registration@nature.com
For print subscription enquiries, please contact our subscription department:
subscriptions@nature.com
For other enquiries, please contact customer feedback department:
feedback@nature.com
Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA
Nature Publishing Group's worldwide offices:
London - Paris - Munich - New Delhi - Tokyo - Melbourne -
San Diego - San Francisco - Washington - New York - Boston
Macmillan Publishers Limited is a company incorporated in England and
Wales under company number 785998 and whose registered office is located
at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS.
(c) Copyright 2008 Nature Publishing Group
======================================================================
